Assenagon Asset Management
ISEE

Assenagon Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Assenagon Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,918
Closed -$718K – 1596
2021
Q4 		$718K Sell
42,918
-265,495
-86% -$4.35M ﹤0.01% 1130
2021
Q3 		$5.01M Sell
308,413
-1,475,948
-83% -$16.1M 0.02% 441
2021
Q2 		$11.3M Buy
+1,784,361
New +$11.5M 0.04% 323
2019
Q4 		– Sell
-216,036
Closed -$242K – 983
2019
Q3 		$242K Sell
216,036
-17,489
-7% -$20.3K ﹤0.01% 775
2019
Q2 		$304K Buy
+233,525
New +$320K ﹤0.01% 914

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Assenagon Asset Management's ISEE Position: Q1 2022 in Review

Assenagon Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2022, closing a stake of 42,918 shares — an estimated $718K sold.

Assenagon Asset Management first reported a position in ISEE in Q2 2019 and held it in 5 quarters. The position peaked at $11.3M in Q2 2021. 163 funds tracked by Wall St. Rank hold ISEE as of Q1 2022.

  • Assenagon Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 42,918 IVERIC bio, Inc. Common Stock shares in Q1 2022, an estimated $718K.
  • Assenagon Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Assenagon Asset Management's IVERIC bio, Inc. Common Stock position peaked at $11.3M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.